- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
AstraZeneca-supported statin materials were ruled disguised promotion for Crestor, with misleading cost/safety content and missing prescribing information. Serious process failures led to…
Anonymous caller alleged Sanofi-Aventis incentivised reps to see key customers 9–12 times, breaching call frequency rules. Panel found targets were team-based and…
A GP alleged a Celebrex journal ad implied guaranteed 100% pain relief. The Panel found the wording was an aspiration and not…
BMJ ad for Versatis said “New for burning, shooting, stabbing pains”. Panel found this implied use beyond PHN (breach 3.2). On appeal,…
A GP said a BMJ ad for Exubera misled on how large the inhaler was. The Panel agreed the artwork implied the…
A GP received Cialis samples by post via an agency and said he hadn’t requested them. The Panel found the rep had…
AstraZeneca’s Arimidex mailer compared 28‑day acquisition costs of aromatase inhibitors under a broad “breast cancer” heading without clarifying differing licensed indications. PMCPA…
Shire’s journal ad claimed Calcichew-D3 Forte was preferred over Adcal-D3 by 80% of patients and implied a pleasant taste. PMCPA found the…
PMCPA case AUTH/3004/12/17 (Director v Gilead) concerning clinical trial disclosure for Sovaldi. Outcome: no breach; matter found to be outwith the scope…
Amicus presented on investigational migalastat at a UK patient organisation network meeting. PMCPA ruled pre-authorisation promotion and lack of certification (Clauses 3.1,…
A member of the public complained to the PMCPA about Mitsubishi regarding clinical trial disclosure for Incivo. The matter was ruled outwith…
Anonymous complaint about Pfizer meeting sponsorship. PMCPA concluded the matter was outwith the scope of the ABPI Code, so no case report…
Ferriprox banner and patient-newsletter content drew breaches for missing prescribing info link (HCP ad), unsubstantiated hanging comparison, and unbalanced public messaging encouraging…
Anonymous complaint alleged repeated advisory boards were disguised promotion with excessive value. Panel found a breach of Clause 9.1 (high standards) due…
Two health boards said a Cipralex letter implied they endorsed use in GAD. A representative had altered a certified template and sent…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.